Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.08%
SPX
-0.22%
IXIC
-0.51%
FTSE
-0.20%
N225
-0.22%
AXJO
-0.21%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest Salarius Pharmaceuticals News

benzinga.com

What's Going On With Salarius Pharmaceuticals Shares Today?

Feature Image for interests on Healthcare, Movers, News, Retail Investor Stocks from benzinga.com
4 days ago
benzinga.com

Deal Dispatch: Biden Punts TikTok Ban To Trump, Plus Another Legacy Retailer Goes Bankrupt

Feature Image for interests on Abbv, Auction, Bankruptcy, Basic Materials from benzinga.com
5 months ago
benzinga.com

Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Feature Image for interests on Apld, Atpc, Avah, Basic Materials from benzinga.com
11 months ago
benzinga.com

Why Selective Insurance Group Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Feature Image for interests on Aehl, Air, Alv, Amix from benzinga.com
11 months ago
finance.yahoo.com

Clinical Data on Salarius Pharmaceuticals’ Seclidemstat in Patients with MDS and CMML Presented at the 2024 European Hematology Association Annual Meeting

Feature Image for interests on Azacitidine, Cancer Therapies, Cmml, Complete Response from finance.yahoo.com
about 1 year ago
finance.yahoo.com

Salarius Pharmaceuticals Announces 1-for-8 Reverse Stock Split

Feature Image for interests on Cancer Therapies, Common Stock, Healthcare, Inc. from finance.yahoo.com
about 1 year ago

Latest Cashu News

publisher logo
Cashu

Salarius Pharmaceuticals Secures Nasdaq Extension to Address Compliance and Innovate Cancer Treatments

1 day ago
publisher logo
Cashu

Salarius Pharmaceuticals (SLRX) Receives Conditional Nasdaq Extension Amid Compliance Challenges

4 days ago
publisher logo
Cashu

Salarius Pharmaceuticals Embraces AI for Enhanced Communication in Biopharmaceuticals

5 months ago
Stocks
Health Care
slrx
Salarius Pharmaceuticals
SLRX
+0.08 (+7.87%)
1.165
USD
At close at Jun 20, 20:40 UTC
Summary
News
Signals
Benchmarks
Financials